Yanlian Liang

Title: Yanlian Liang: Innovator in Blood Group Genotyping

Introduction

Yanlian Liang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of blood group genotyping, particularly through his innovative methods and kits that utilize next-generation sequencing technology.

Latest Patents

Yanlian Liang holds a patent for a "Method and kit for genotyping of multi-system red blood cell (RBC) blood group based on next-generation sequencing (NGS)." This invention provides a method and kit that enable the rapid genotyping of 17 RBC blood group systems and multiple key rare blood groups. The technology employs multiplex PCR capture primer sets and amplification reaction conditions designed for the Illumina platform. This allows for the simultaneous detection of full-length coding regions and spliced flanking regions of 25 blood group genes across three reactions. The method boasts high detection efficiency and low average costs, overcoming limitations of existing blood group gene detection technologies.

Career Highlights

Yanlian Liang is currently associated with the Shenzhen Blood Center, where he continues to advance research in blood group genotyping. His work has been instrumental in enhancing the accuracy and efficiency of blood group gene detection.

Collaborations

He collaborates with notable colleagues, including Shuang Liang and Jinfeng Zeng, contributing to the collective expertise in their field.

Conclusion

Yanlian Liang's innovative work in blood group genotyping exemplifies the impact of modern technology on medical diagnostics. His contributions are paving the way for more efficient and accurate blood group testing methods.